United Services Automobile Association Bluebird Bio, Inc. Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$59.47 - $93.1 $2.47 Million - $3.86 Million	-41,505 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$75.84 - $105.21 $23,131 - $32,089	305 Added 0.74%	41,505 $5.28 Million
Q4 2018 Feb 13, 2019	BUY	$59.1 - $93.26 $302,887 - $477,957	5,125 Added 14.21%	41,200 $4.09 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $187,583 - $248,021	2,111 Added 6.22%	36,075 $5.27 Million
Q2 2018 Sep 27, 2018	SELL	$99.64 - $127.59 $9.63 Million - $12.3 Million	-96,648 Reduced 74.0%	33,964 $5.33 Million
Q2 2018 Aug 10, 2018	BUY	$99.64 - $127.59 $9.6 Million - $12.3 Million	96,324 Added 280.93%	130,612 $17.2 Million
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $746,101 - $1.06 Million	7,052 Added 25.89%	34,288 $5.86 Million
Q4 2017 Feb 14, 2018	SELL	$81.25 - $130.7 $209,137 - $336,421	-2,574 Reduced 8.63%	27,236 $4.85 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $1.72 Million - $2.73 Million	29,810	29,810 $4.09 Million

42.6M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $466M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.